Literature DB >> 17544227

Non-medical use, abuse and dependence on sedatives and tranquilizers among U.S. adults: psychiatric and socio-demographic correlates.

William C Becker1, David A Fiellin, Rani A Desai.   

Abstract

BACKGROUND: Non-medical use of sedatives and tranquilizers carries risks including development of abuse/dependence. Such use may correlate with psychiatric symptoms.
METHODS: Cross-sectional survey, the 2002-2004 National Survey on Drug Use and Health. Respondents 18 years and older (n=92,020). Bivariate and multivariable associations were investigated.
RESULTS: The prevalence of past-year non-medical use of sedatives or tranquilizers was 2.3%. Of those with non-medical use, 9.8% met criteria for abuse/dependence. On multivariable analysis, panic symptoms and elevated serious mental illness scores were associated with past-year non-medical use. Also, the following past-year socio-demographic and substance use covariates were associated with past-year non-medical sedative or tranquilizer use: female sex, white/hispanic/other ethnicity, criminal arrest, uninsurance, unemployment, alcohol abuse or dependence, cigarette use, illicit drug use, younger age of initiating illicit substance use, and any history of IV drug use. Among those with sedative or tranquilizer use, those with abuse/dependence were more likely to have agoraphobic symptoms. In addition, they were more likely to be older, unmarried, have a low education level and have been arrested.
CONCLUSIONS: Non-medical use of sedatives and tranquilizers is common. Furthermore, nearly 10% of those with non-medical use meet criteria for abuse/dependence. Anxiety symptoms associated with non-medical use (panic symptoms) and abuse/dependence (agoraphobia) should alert clinicians to screen for these problems and consider alternate treatment or referral.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17544227      PMCID: PMC3745028          DOI: 10.1016/j.drugalcdep.2007.04.009

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  22 in total

1.  Reinforcing effects of diazepam under anxiogenic conditions in individuals with social anxiety.

Authors:  Todd C Helmus; Manuel Tancer; Chris-Ellyn Johanson
Journal:  Exp Clin Psychopharmacol       Date:  2005-11       Impact factor: 3.157

Review 2.  Drug dependence: stress and dysregulation of brain reward pathways.

Authors:  M J Kreek; G F Koob
Journal:  Drug Alcohol Depend       Date:  1998 Jun-Jul       Impact factor: 4.492

3.  Analgesic use disorders among orthopedic and chronic pain patients at a rehabilitation clinic.

Authors:  U Jonasson; B Jonasson; L Wickström; E Andersson; T Saldeen
Journal:  Subst Use Misuse       Date:  1998-05       Impact factor: 2.164

4.  Gender differences in response to lorazepam in a human drug discrimination study.

Authors:  Anne Jackson; David Stephens; Theodora Duka
Journal:  J Psychopharmacol       Date:  2005-11       Impact factor: 4.153

Review 5.  Benzodiazepine use, abuse, and dependence.

Authors:  Charles P O'brien
Journal:  J Clin Psychiatry       Date:  2005       Impact factor: 4.384

6.  Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.

Authors:  R C Kessler; K A McGonagle; S Zhao; C B Nelson; M Hughes; S Eshleman; H U Wittchen; K S Kendler
Journal:  Arch Gen Psychiatry       Date:  1994-01

7.  Anxiolytics' effects on the actual driving performance of patients and healthy volunteers in a standardized test. An integration of three studies.

Authors:  J F O'Hanlon; A Vermeeren; M M Uiterwijk; L M van Veggel; H F Swijgman
Journal:  Neuropsychobiology       Date:  1995       Impact factor: 2.328

8.  Preferences for ethanol and diazepam in anxious individuals: an evaluation of the self-medication hypothesis.

Authors:  M A Chutuape; H de Wit
Journal:  Psychopharmacology (Berl)       Date:  1995-09       Impact factor: 4.530

9.  Clinical aspects of chronic use of alprazolam and lorazepam.

Authors:  M Romach; U Busto; G Somer; H L Kaplan; E Sellers
Journal:  Am J Psychiatry       Date:  1995-08       Impact factor: 18.112

Review 10.  Medications and the older driver.

Authors:  W A Ray; P B Thapa; R I Shorr
Journal:  Clin Geriatr Med       Date:  1993-05       Impact factor: 3.076

View more
  26 in total

1.  Attributions about Addiction among Latina Women.

Authors:  Frank Dillon; Mario De La Rosa; Patria Rojas; Seth J Schwartz; Rui Duan
Journal:  J Soc Work Pract Addict       Date:  2011-07

2.  Race-Ethnicity and Prescription Drug Misuse: Does Self-esteem Matter?

Authors:  Clifford L Broman; Paula K Miller; Emmanuel Jackson
Journal:  J Child Adolesc Behav       Date:  2015-09-03

3.  The epidemiology of benzodiazepine misuse: A systematic review.

Authors:  Victoria R Votaw; Rachel Geyer; Maya M Rieselbach; R Kathryn McHugh
Journal:  Drug Alcohol Depend       Date:  2019-05-07       Impact factor: 4.492

4.  Benzodiazepine Dependence among Young Adult Participants in the Club Scene Who Use Drugs.

Authors:  Steven P Kurtz; Mance E Buttram; Hilary L Surratt
Journal:  J Psychoactive Drugs       Date:  2016-12-21

5.  Benzodiazepine dependence among multidrug users in the club scene.

Authors:  Steven P Kurtz; Hilary L Surratt; Maria A Levi-Minzi; Angela Mooss
Journal:  Drug Alcohol Depend       Date:  2011-06-25       Impact factor: 4.492

6.  Subtypes of adolescent sedative/anxiolytic misusers: A latent profile analysis.

Authors:  Martin T Hall; Matthew O Howard; Sean Esteban McCabe
Journal:  Addict Behav       Date:  2010-06-04       Impact factor: 3.913

7.  Benzodiazepine Use and Misuse Among Adults in the United States.

Authors:  Donovan T Maust; Lewei A Lin; Frederic C Blow
Journal:  Psychiatr Serv       Date:  2018-12-17       Impact factor: 3.084

8.  Sex differences in nonmedical prescription tranquilizer and stimulant use trends among secondary school students in Argentina, Chile, and Uruguay.

Authors:  Alexander S Perlmutter; Ariadne E Rivera-Aguirre; Pia M Mauro; Alvaro Castillo-Carniglia; Nicolás Rodriguez; Nora Cadenas; Magdalena Cerdá; Silvia S Martins
Journal:  Drug Alcohol Depend       Date:  2019-10-04       Impact factor: 4.492

9.  Factors predicting development of opioid use disorders among individuals who receive an initial opioid prescription: mathematical modeling using a database of commercially-insured individuals.

Authors:  Bryan N Cochran; Annesa Flentje; Nicholas C Heck; Jill Van Den Bos; Dan Perlman; Jorge Torres; Robert Valuck; Jean Carter
Journal:  Drug Alcohol Depend       Date:  2014-03-12       Impact factor: 4.492

10.  Correlates of extramedical use of OxyContin versus other analgesic opioids among the US general population.

Authors:  Silvia S Martins; Carla L Storr; Hong Zhu; Howard D Chilcoat
Journal:  Drug Alcohol Depend       Date:  2008-08-15       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.